AFT

AFT Pharmaceuticals Limited - Announcements

1.85%

$2.75

Healthcare Biotechnology

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AFT	Results of 2025 Annual Shareholder Meeting		145.13KB	Share
AFT	2025 ASM Release, Chairs address & presentation		116.41KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Intere		515.5KB	Share
AFT	June Quarter FY 2026 Investor Update		168.96KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Intere		490.64KB	Share
AFT	Notice of Annual Meeting of Shareholders 2025		158.22KB	Share
AFT	Annual Meeting and Closing Date for Director Nominations		119.69KB	Share
AFT	AFT and Hikma extend US Maxigesic Cooperation		113.37KB	Share
AFT	Corrected Distribution Notice		121.71KB	Share
AFT	AFT sees strong FY 26 as revenue reaches new record	PRICE SENSITIVE	163.16KB	Share
AFT	AFT to announce full year results on Thursday May 22 2025		89.91KB	Share
AFT	March investor update		165.33KB	Share
AFT	ASX Small Cap presentation 250326		2.84MB	Share
AFT	NEW YEAR LETTER TO INVESTORS		202.58KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Intere		491.05KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Int		491.93KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Int		558.92KB	Share
AFT	AFT reports record sales and invests for growth	PRICE SENSITIVE	210.83KB	Share
AFT	AFT appoints Allison Yorston as independent director		109.84KB	Share
AFT	SPH Notice - Accident Compensation Corporation (ACC)		76.13KB	Share
AFT	AFT trading update	PRICE SENSITIVE	110.45KB	Share
AFT	AFT enters late-stage R&D agreement for a novel injectable		111.66KB	Share
AFT	Interim results announcement Thurs Nov 21 2024		89.03KB	Share
AFT	AFT Licenses Maxigesic IV in China and USA update		116.94KB	Share
AFT	AFT adds COMBOGESIC Tablets to Hikma Agreement in US		128.65KB	Share
AFT	results of 2024 ASM		145.8KB	Share
AFT	2024 ASM Chairs address & presentation		109.54KB	Share
AFT	AFT agrees distribution for Crystaderm in China		112.28KB	Share
AFT	Retirement of Anita Baldauf		106.67KB	Share
AFT	Notice of Annual Meeting of Shareholders 2024		161.89KB	Share
AFT	AFT to launch Maxigesic(R) Rapid in the United States	PRICE SENSITIVE	112.7KB	Share
AFT	Annual Meeting and Closing Date for Director Nominations		119.53KB	Share
AFT	Distribution notice	PRICE SENSITIVE	120.13KB	Share
AFT	AFT reports record revenue and earnings	PRICE SENSITIVE	173.39KB	Share
AFT	SPH Notice - Accident Compensation Corporation (ACC)		73.72KB	Share
AFT	AFT to announce full year results on May 23 2024		89.21KB	Share
AFT	AFT Licenses Maxigesic(R) IV in Brazil		113.62KB	Share
AFT	AFT,Massey Ventures,Gilles McIndoe to develop scar treatmen		117.85KB	Share
AFT	AFT makes further progress in international markets		122.8KB	Share
AFT	AFT updates operating profit guidance to $23m to $25m	PRICE SENSITIVE	144.72KB	Share
AFT	Maxigesic IV launched in the United States	PRICE SENSITIVE	346.8KB	Share
AFT	AFT further broadens R&D pipeline with new product		115.99KB	Share
AFT	NEW YEAR LETTER TO INVESTORS		172.04KB	Share
AFT	AFT broadens R&D pipeline with new product candidate		114.16KB	Share
AFT	AFT Pharma reports growth and global expansion	PRICE SENSITIVE	183.91KB	Share
AFT	AFT's Crystaderm(R) antiseptic approved for sale in China		109.88KB	Share
AFT	AFT welcomes US FDA approval for sale of Maxigesic IV	PRICE SENSITIVE	119.23KB	Share
AFT	AFT to announce half year interim results on Thurs Nov 23		88.73KB	Share
AFT	Retirement of Jon Lamb		106.26KB	Share
AFT	AFT appoints Andrew Lane as independent director		109.96KB	Share
AFT	Shareholder interests		406.75KB	Share
AFT	AFT Orphan Pharmaceuticals judgment		142.93KB	Share
AFT	Results of 2023 Annual Shareholder Meeting		143.6KB	Share
AFT	Jon Lamb intention to retire		106.27KB	Share
AFT	ASM chair address and presentation		158.12KB	Share
AFT	AFT signs new licensing agreement for ZENEO(R) Midazolam		258.22KB	Share
AFT	AFT extends e-commerce presence into Amazon US		124.04KB	Share
AFT	Notice of Annual Meeting of Shareholders 2023		417.29KB	Share
AFT	Annual Meeting and Closing Date for Director Nominations		119.52KB	Share
AFT	NOTICE PURSUANT TO LISTING RULE 7.12.1		162.45KB	Share
AFT	Distribution Notice		120.5KB	Share
AFT	AFT declares maiden dividend; record revenue	PRICE SENSITIVE	1.67MB	Share
AFT	AFT Pharmaceuticals to announce full year results on Monday		107.66KB	Share
AFT	US FDA sets PDUFA date for Maxigesic IV		143.12KB	Share
AFT	AFT submits Maxigesic IV(R) packaging data to the US FDA		123.37KB	Share
AFT	AFT Crystawash reg'n in China and new licencing agreements		103.68KB	Share
AFT	Maxigesic Rapid tablets gain US FDA approval	PRICE SENSITIVE	102.55KB	Share
AFT	AFT to develop antibiotic eye drop		117.2KB	Share
AFT	AFT announces Maxigesic IV(R) distribution agreement for nine		153.82KB	Share
AFT	2023 New Year letter to investors		182.52KB	Share
AFT	221124 Interim results FY23H1 App 2 amended	PRICE SENSITIVE	184.12KB	Share
AFT	AFT extends growth investment as sales surge	PRICE SENSITIVE	154.45KB	Share
AFT	AFT to announce half year interim results on Nov 24		88.58KB	Share
AFT	AFT update on Maxigesic IV(R) US registration filing		111.45KB	Share
AFT	AFT collaborates to develop birthmark medicine		119.91KB	Share
AFT	Results of 2022 Annual Shareholder Meeting		144.49KB	Share
AFT	AFT 2022 ASM chairman's address and presentation		161.82KB	Share
AFT	AFT Completes Pascomer Clinical Study and Takes Back Rights		294.81KB	Share
AFT	Dr Doug Wilson to step down from AFT Board		112.99KB	Share
AFT	AFT and RooLife launch OTC medicines online in China		124.81KB	Share
AFT	Notice of Annual Meeting of Shareholders 2022		433.07KB	Share
AFT	US FDA seeks more information on Maxigesic IV(R) application	PRICE SENSITIVE	137KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Intere		434.8KB	Share
AFT	Capital Change Notice - Issue of ordinary shares		123.17KB	Share
AFT	Annual Meeting and Closing Date for Director Nominations		119.59KB	Share
AFT	Capital Change Notice - Issue of ordinary shares		123.27KB	Share
AFT	Annual Report revision	PRICE SENSITIVE	7.6MB	Share
AFT	AFT full year results FY2022	PRICE SENSITIVE	187.22KB	Share
AFT	Capital Change Notice - Issue of ordinary shares		123.26KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Intere		434.04KB	Share
AFT	Capital Change Notice - Issue of ordinary shares		123.19KB	Share
AFT	AFT to announce full year results on Monday May 23 2022		87.35KB	Share
AFT	Capital Change Notice - Issue of ordinary shares		122.81KB	Share
AFT	AFT prevails in comparative advertising judgement		121.01KB	Share
AFT	AFT notes FDA approval for Pascomer alternative		116.08KB	Share
AFT	ASX farmaforce release on contract sales force partnership		293.61KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Intere		436.96KB	Share
AFT	2022 New Year letter to investors		330.37KB	Share
AFT	Disclosure of Directors and Senior Managers Relevant Intere		291.76KB	Share
AFT	AFT welcomes Australian Federal Court appeal success		115.53KB	Share

AFT Results of 2025 Annual Shareholder Meeting
04/08/25		145.13KB	Share
AFT 2025 ASM Release, Chairs address & presentation
01/08/25		116.41KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Intere
04/07/25		515.5KB	Share
AFT June Quarter FY 2026 Investor Update
01/07/25		168.96KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Intere
27/06/25		490.64KB	Share
AFT Notice of Annual Meeting of Shareholders 2025
27/06/25		158.22KB	Share
AFT Annual Meeting and Closing Date for Director Nominations
30/05/25		119.69KB	Share
AFT AFT and Hikma extend US Maxigesic Cooperation
26/05/25		113.37KB	Share
AFT Corrected Distribution Notice
22/05/25		121.71KB	Share
AFT AFT sees strong FY 26 as revenue reaches new record
22/05/25	PRICE SENSITIVE	163.16KB	Share
AFT AFT to announce full year results on Thursday May 22 2025
01/05/25		89.91KB	Share
AFT March investor update
31/03/25		165.33KB	Share
AFT ASX Small Cap presentation 250326
26/03/25		2.84MB	Share
AFT NEW YEAR LETTER TO INVESTORS
13/01/25		202.58KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Intere
02/12/24		491.05KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Int
27/11/24		491.93KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Int
27/11/24		558.92KB	Share
AFT AFT reports record sales and invests for growth
21/11/24	PRICE SENSITIVE	210.83KB	Share
AFT AFT appoints Allison Yorston as independent director
13/11/24		109.84KB	Share
AFT SPH Notice - Accident Compensation Corporation (ACC)
07/11/24		76.13KB	Share
AFT AFT trading update
01/11/24	PRICE SENSITIVE	110.45KB	Share
AFT AFT enters late-stage R&D agreement for a novel injectable
21/10/24		111.66KB	Share
AFT Interim results announcement Thurs Nov 21 2024
11/10/24		89.03KB	Share
AFT AFT Licenses Maxigesic IV in China and USA update
30/09/24		116.94KB	Share
AFT AFT adds COMBOGESIC Tablets to Hikma Agreement in US
08/08/24		128.65KB	Share
AFT results of 2024 ASM
02/08/24		145.8KB	Share
AFT 2024 ASM Chairs address & presentation
02/08/24		109.54KB	Share
AFT AFT agrees distribution for Crystaderm in China
09/07/24		112.28KB	Share
AFT Retirement of Anita Baldauf
01/07/24		106.67KB	Share
AFT Notice of Annual Meeting of Shareholders 2024
01/07/24		161.89KB	Share
AFT AFT to launch Maxigesic(R) Rapid in the United States
04/06/24	PRICE SENSITIVE	112.7KB	Share
AFT Annual Meeting and Closing Date for Director Nominations
31/05/24		119.53KB	Share
AFT Distribution notice
23/05/24	PRICE SENSITIVE	120.13KB	Share
AFT AFT reports record revenue and earnings
23/05/24	PRICE SENSITIVE	173.39KB	Share
AFT SPH Notice - Accident Compensation Corporation (ACC)
15/05/24		73.72KB	Share
AFT AFT to announce full year results on May 23 2024
03/05/24		89.21KB	Share
AFT AFT Licenses Maxigesic(R) IV in Brazil
01/05/24		113.62KB	Share
AFT AFT,Massey Ventures,Gilles McIndoe to develop scar treatmen
24/04/24		117.85KB	Share
AFT AFT makes further progress in international markets
04/03/24		122.8KB	Share
AFT AFT updates operating profit guidance to $23m to $25m
16/02/24	PRICE SENSITIVE	144.72KB	Share
AFT Maxigesic IV launched in the United States
07/02/24	PRICE SENSITIVE	346.8KB	Share
AFT AFT further broadens R&D pipeline with new product
19/01/24		115.99KB	Share
AFT NEW YEAR LETTER TO INVESTORS
09/01/24		172.04KB	Share
AFT AFT broadens R&D pipeline with new product candidate
22/12/23		114.16KB	Share
AFT AFT Pharma reports growth and global expansion
23/11/23	PRICE SENSITIVE	183.91KB	Share
AFT AFT's Crystaderm(R) antiseptic approved for sale in China
21/11/23		109.88KB	Share
AFT AFT welcomes US FDA approval for sale of Maxigesic IV
18/10/23	PRICE SENSITIVE	119.23KB	Share
AFT AFT to announce half year interim results on Thurs Nov 23
09/10/23		88.73KB	Share
AFT Retirement of Jon Lamb
28/09/23		106.26KB	Share
AFT AFT appoints Andrew Lane as independent director
28/09/23		109.96KB	Share
AFT Shareholder interests
18/09/23		406.75KB	Share
AFT AFT Orphan Pharmaceuticals judgment
29/08/23		142.93KB	Share
AFT Results of 2023 Annual Shareholder Meeting
04/08/23		143.6KB	Share
AFT Jon Lamb intention to retire
04/08/23		106.27KB	Share
AFT ASM chair address and presentation
04/08/23		158.12KB	Share
AFT AFT signs new licensing agreement for ZENEO(R) Midazolam
21/07/23		258.22KB	Share
AFT AFT extends e-commerce presence into Amazon US
11/07/23		124.04KB	Share
AFT Notice of Annual Meeting of Shareholders 2023
30/06/23		417.29KB	Share
AFT Annual Meeting and Closing Date for Director Nominations
26/05/23		119.52KB	Share
AFT NOTICE PURSUANT TO LISTING RULE 7.12.1
22/05/23		162.45KB	Share
AFT Distribution Notice
22/05/23		120.5KB	Share
AFT AFT declares maiden dividend; record revenue
22/05/23	PRICE SENSITIVE	1.67MB	Share
AFT AFT Pharmaceuticals to announce full year results on Monday
04/05/23		107.66KB	Share
AFT US FDA sets PDUFA date for Maxigesic IV
01/05/23		143.12KB	Share
AFT AFT submits Maxigesic IV(R) packaging data to the US FDA
18/04/23		123.37KB	Share
AFT AFT Crystawash reg'n in China and new licencing agreements
27/03/23		103.68KB	Share
AFT Maxigesic Rapid tablets gain US FDA approval
02/03/23	PRICE SENSITIVE	102.55KB	Share
AFT AFT to develop antibiotic eye drop
02/02/23		117.2KB	Share
AFT AFT announces Maxigesic IV(R) distribution agreement for nine
24/01/23		153.82KB	Share
AFT 2023 New Year letter to investors
09/01/23		182.52KB	Share
AFT 221124 Interim results FY23H1 App 2 amended
24/11/22	PRICE SENSITIVE	184.12KB	Share
AFT AFT extends growth investment as sales surge
24/11/22	PRICE SENSITIVE	154.45KB	Share
AFT AFT to announce half year interim results on Nov 24
10/10/22		88.58KB	Share
AFT AFT update on Maxigesic IV(R) US registration filing
02/09/22		111.45KB	Share
AFT AFT collaborates to develop birthmark medicine
01/09/22		119.91KB	Share
AFT Results of 2022 Annual Shareholder Meeting
05/08/22		144.49KB	Share
AFT AFT 2022 ASM chairman's address and presentation
05/08/22		161.82KB	Share
AFT AFT Completes Pascomer Clinical Study and Takes Back Rights
27/07/22		294.81KB	Share
AFT Dr Doug Wilson to step down from AFT Board
22/07/22		112.99KB	Share
AFT AFT and RooLife launch OTC medicines online in China
07/07/22		124.81KB	Share
AFT Notice of Annual Meeting of Shareholders 2022
05/07/22		433.07KB	Share
AFT US FDA seeks more information on Maxigesic IV(R) application
01/07/22	PRICE SENSITIVE	137KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Intere
20/06/22		434.8KB	Share
AFT Capital Change Notice - Issue of ordinary shares
20/06/22		123.17KB	Share
AFT Annual Meeting and Closing Date for Director Nominations
30/05/22		119.59KB	Share
AFT Capital Change Notice - Issue of ordinary shares
26/05/22		123.27KB	Share
AFT Annual Report revision
23/05/22	PRICE SENSITIVE	7.6MB	Share
AFT AFT full year results FY2022
23/05/22	PRICE SENSITIVE	187.22KB	Share
AFT Capital Change Notice - Issue of ordinary shares
11/05/22		123.26KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Intere
05/05/22		434.04KB	Share
AFT Capital Change Notice - Issue of ordinary shares
05/05/22		123.19KB	Share
AFT AFT to announce full year results on Monday May 23 2022
04/05/22		87.35KB	Share
AFT Capital Change Notice - Issue of ordinary shares
28/04/22		122.81KB	Share
AFT AFT prevails in comparative advertising judgement
08/04/22		121.01KB	Share
AFT AFT notes FDA approval for Pascomer alternative
05/04/22		116.08KB	Share
AFT ASX farmaforce release on contract sales force partnership
23/02/22		293.61KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Intere
13/01/22		436.96KB	Share
AFT 2022 New Year letter to investors
07/01/22		330.37KB	Share
AFT Disclosure of Directors and Senior Managers Relevant Intere
22/12/21		291.76KB	Share
AFT AFT welcomes Australian Federal Court appeal success
09/12/21		115.53KB	Share

REFRESH

1 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.75		Change 0.050(1.85%)		Mkt cap ! n/a

Open	High	Low	Value	Volume
$2.72	$2.75	$2.69	$34.18K	12.52K

Buyers (Bids)

No.	Vol.	Price($)
0	29	$2.75

Sellers (Offers)

Price($)	Vol.	No.
$2.76	1448	0

Last trade - 13.00pm 29/08/2025 (20 minute delay)

AFT (NZSX) Chart

AFT Pharmaceuticals Limited - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available